Calian Group Ltd.

Good day, and thank you for standing by. Welcome to the CALIAN Group first quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference has been recorded. I would now like to hand the conference over to your speaker today, Jennifer McCaughey, Director of Investor Relations. Please go ahead.

Thank you, Shannon, and good morning, everyone. Thank you for joining us for Callion's Q1 and fiscal year 2024 conference call. Presenting this morning are Kevin Ford, Chief Executive Officer, and Patrick Houston, Chief Financial Officer. As noted on slide two, please be advised that certain information discussed today is forward-looking, and subject to important risks and uncertainties. The results predicted in these statements may be materially different from actual results. As a reminder, all amounts are expressed in Canadian dollars, except as otherwise specified. With that, let me turn the call over to Kevin.

Good morning, and thank you, Jennifer. I'd like to start by saying that you will increasingly hear me talk about Callion on a consolidated basis. While we manage the different segments as distinct P&Ls, We're judging the performance of the company on a consolidated basis. Now for some Q1 highlights. We had a strong start to the year with revenues up 21% driven by double-digit organic growth and the contribution from two recent acquisitions. Organic growth outpaced M&A growth this quarter. Steps to improve our efficiency are bearing fruit with gross margin at an all-time high of 32.5% and adjusted EBITDA margin bordering 11%. These results demonstrate the strength of our business model, our diversification in new markets and offerings, as well as the value creation generated from our M&A agenda. In fact, our M&A engine is working with the completion of two acquisitions in the past six months for a total consideration of approximately $100 million. Notable highlights in Q1 include the completion of the decisive acquisition, which will form a key part of our ITS strength in North America, And we welcome Michael Trombley as president of our IT and cyber services group. The contribution from our recent acquisition of Hawaii Pacific Teleport continues to be a highlight. And our sales engine was able to secure $150 million in new signings this quarter. Given these strong results, we are reiterating our fiscal 24 guidance, which puts us on track to deliver our seventh consecutive year of double-digit profitable revenue growth. This strong performance is an early indicator of our path to reach $1 million in revenues by the end of fiscal 26. Now, I will turn over to Patrick to discuss consolidated results and guidance for fiscal 24. Over to you, Patrick.

Thank you, Kevin. Q1 revenues reached $179 million, up 21% compared to the same period last year, and represents the highest revenue quarter in our history. This increase was driven by growth across all four segments, including double-digit growth in health, ITCS, and advanced technologies. Acquisitive growth was 9% and was generated by the acquisitions of HPT and Decisive. Organic growth was 12% and was mainly driven by double-digit growth in health and advanced technologies. Our steps to restore efficiency are clearly working. Gross margin reached a record 32.5%, representing a seventh consecutive quarter above 30%, and the first time above 32%. Adjusted EBITDA increased 37% to $20 million, driven by strength, overall revenue growth, and margin expansion in advanced technologies and health, as well as from benefits generated from the restructuring plan implemented midway through our fourth quarter. Adjusted EBITDA margin reached 10.9%, up from 9.7% in the previous year. In Q1, we signed $150 million in gross new contracts. and ended the quarter with a backlog of $1.1 billion, positioning us well for the balance of this year and into FY25. Net profit in Q1 increased to $5.5 million or $0.46 per diluted share compared to $4.6 million or $0.39 per share for the same period last year. The increase was mainly driven by higher adjusted EBITDA, partially offset by higher expenses related to acquisitions. and higher interest expenses as we drew on our credit facility to fund the acquisitions of HPT and Decisive. Noted in FY24, we are expecting to pay the year to earn out for Simfront. This amount is recorded on our balance sheet. We generated cash flow from operations of $18 million in Q1, down from $25 million last year. Working capital was neutral in the quarter, while we had significant recapture in Q1 of last year. When we take working capital on our balance sheet and put it in relation to our revenue generation, we've made great strides in recent years. In FY20, we required $92 million in working capital to generate $432 million of revenue, or 21% efficiency. In FY23, we now required $90 million to generate $659 million of revenues, or 14% efficiency. In Q1, we required $71 million of working capital to generate the last 12 months of revenue of almost $700 million, or 10%. Going forward, we'll be looking to drive more efficiency in working capital as we continue to deliver double-digit revenue growth. Operating free cash flow was up 17% to $14 million and represented a 73% conversion from adjusted EBITDA. Looking at it through a shareholder lens, our operating free cash flow per share increased 15% to $1.20 per share. We continue to have a disciplined and balanced approach to capital deployment in the first quarter. We invested in our business with the acquisition of Decisive for $47 million. We also made CapEx investments of $2 million. Our CapEx levels have remained stable despite significant increase in the size of our business over the last few years. We continue to invest in capital to help us scale and not inhibit our growth aspirations. We also provide a return to shareholders in the form of a dividend and share repurchases. We pay dividends of $3 million or $0.28 per share. representing 23% of operating free cash flows. In Q1, we continued to repurchase shares through our NCIB program we put in place on September 1st. We purchased 27,226 shares for cancellation for approximately $1 million. Since the launch of the NCIB plan, we've repurchased just under 60,000 shares for cancellation of approximately $3 million. Although we believe our share price remains undervalued, our capital allocation priority is still our M&A agenda. As a result, any future dividend increases or share repurchase decisions will be evaluated in the context of this while being mindful of our leverage. After making all these investments, we ended the quarter with a solid balance sheet. As of December 31st, we had drawn $94 million on our debt facility, and we had net debt of $41 million. and a net debt to EBITDA ratio of 0.6 times, well below our target of 2.5 times. We maintain considerable debt capacity with our existing lenders and staying within our 2.5 times EBITDA leverage target to further fund our M&A agenda. Let's take a look at our guidance for FY24. Given our strong start to the year and our confidence for the balance of the year, we are reiterating our guidance. As a reminder, we expect revenues in the range of $730 to $790 million for the year ended September 30, 2024. At the midpoint, this reflects revenue growth of 15%. This would represent our seventh consecutive year of double-digit growth and record levels. In this guidance, the acquisition of the HPT and Decisive represent approximately 7% acquisitive growth over last year. At the midpoint of the range, organic growth would represent 8%. When taking into account Q1 revenues of 179 million, our 342 million of backlogged earmarked for the remainder of FY24, our deferred revenues of 30 million, and our recurring revenue streams of approximately 30 million, we have 76% of FY24 already booked and ready to deliver. In terms of profitability, we expect adjusted EBITDA in the range of 83 to 89 million. At the midpoint, it reflects adjusted EBITDA growth of 30%, significantly outpacing our revenue growth. This is a result of expanding our business into higher margin areas as well as the full-year benefit of our restructuring plan. It also implies a margin of 11.3%. With this guidance, we're on track to achieve another record year at FY24 and are off to a great start to achieve our $1 billion revenue target by the end of FY26. As a reminder, we're expecting to see increased fluctuation in our quarterly results due to our revenue mix, which is more highly skewed towards products, where the timing of deliveries come into play, as well as commercial customers characterized by greater demand variability. As always, we must caution that this guidance is ultimately dependent on the extent and timing of future contract awards and customer realization of existing contract vehicles. The guidance also implies no major changes to current economic environments, defense spending, and supply chains as well as no major increases in interest rates or labor costs. Note that our guidance does not incorporate any additional M&A activity than those already mentioned, and should we close any new opportunities, their contributions would be incremental. Finally, in terms of capital deployment for the year, earn out payments should be approximately $3 million. We continue to have a robust pipeline of acquisitions, and we're working hard to close a few of those in the balance of FY24. We expect to maintain our capex investments in the range of $8 to $10 million and our current dividend at $1.12 per share. We believe this guidance reflects the strength of our business and momentum coming off a very strong quarter. I'll now turn the call back over to Kevin to provide color on our business segment. Kevin?

Thank you, Patrick. Let me start with our ITCS segment. As mentioned, major highlights in this quarter include the start of Mike Tremblay as president and the acquisition of Decisive, and continued margin recovery. Mike has been on board for about two months now, and has met with the teams in Ottawa, Toronto, and Houston, and has quickly assessed the people and assets we have. He is already implementing changes to our strategy and go-to-market business model, which is expected to just support higher sales generation. Recall that Decisive closed December 1st, so it has only contributed one month and a quarter. Early interactions with the excellent team, as well as key customers, have been positive, and we believe this acquisition will be a great asset moving forward. When looking at our EBITDA margins, we are back in the 14% range, similar to where we were at the beginning of last year. These are solid signs that the assets in our ITCS business are strong, and I look forward to working with Mike to drive future growth across North America. We also entered Q1 with new contract signings of $62 million, an indication that bookings continue to be healthy. With the full-year benefit and the cost reductions implemented in Q4 and the addition of Decisive, which complements and rounds out our current IT and cyber solutions portfolio in North America, we are well-positioned to extract a lot of synergies over the next 24 months. Turning to our health segment. The major highlights this quarter are the continued growth momentum, both from a top-line and profitability perspective, digital opportunities on the horizon, and investments in growth. We had a strong performance coming off of record Q4 with revenues up over 24% and adjusted EBITDA up 46%. This growth is all organic. We continue to experience strong demand from our long-standing customers, as well as short-term health response demand, which is characterized by higher margins. Furthermore, we're seeing exciting opportunities in our digital platform. We onboarded two customers so far and have a promising pipeline. These early wins reinforce our willingness to invest more, and in fact, we'll be investing in our sales capacity to get more feet on the streets to sell both our service and digital product portfolio. With new contract signings of $40 million and a solid backlog of $626 million, we believe that revenues of $200 million per year are in sight for the first time in the company's history. The M&A environment and health has improved, and we are looking to deploy capital to further accelerate our growth in this segment. Turning to our learning segment. as we mentioned last quarter the pace of growth for learning has started to slow down due to longer procurement decisions however we continue to see strong activity from existing customers driven by global conflicts and a renewed focus on readiness what is exciting is that we are seeing some good defense opportunities both domestically and globally as well as in the commercial market we recently hired a vp sales to help bring them to fruition At the same time, we're also continuing to invest in growth to make sure we are well positioned to capitalize on the macro environment where military training is mission critical. We believe the global defense market will yield future opportunities. It is just a matter of time. In the balance of the year, we will focus on upping our sales engine, unlocking opportunities and targeting acquisitions to strengthen our presence in Europe, and complement our diversification and innovation strategy. Turning to our advanced tech segment. The major highlights for Advanced Tech this quarter are its continued growth momentum, especially with its product portfolio and the solid contribution from Hawaii Pacific Teleport. We are pleased to see AT have a strong start to the year, continuing the momentum generated in the latter part of last year. Revenues increased 49% to $51 million from $34 million last year when the segment was dealing with supply chain issues. This represents the second consecutive quarter above the $50 million mark for our Advanced Technologies Group. This performance was driven in part by the space segment, mainly from performance from our software business and the first full quarter contribution from HPT. This top line growth was also driven by a terrestrial segment where our products portfolio including GNSS, AgTech and nuclear continue to demonstrate significant growth. We have not spoken about defense and AT recently, however, we do see signs of increased demand as procurement starts to finalize plans on large capital programs. It's just a matter of time before these opportunities turn to revenue. Given this higher volume and sales mix, gross margins hit an all-time record above 36%, and adjusted EBITDA more than doubled to $9 million. With continued strong demand for our products, the contribution from HPT, new contract signings of $44 million, and a solid backlog of $142 million, we expect to surpass the $200 million revenue in FY24 again for the first time in company history. EBITDA margins should also increase given the higher margin HPT contribution and favorable revenue mix. Lastly, I wanted to announce that Patrick Thera, President of Advanced Technologies, recently informed us that he will be retiring after illustrious 38-year career with Calium. Patrick played a pivotal role in shaping the success of the Advanced Technologies segment. I am immensely grateful for his dedication, stage counsel, and commitment to the business. We will remain at the helm of the segment while we conduct a search for a successor and we look forward to working on a successful transition. In conclusion, I'd like to leave you with three key takeaways. One, our guidance reflects another double digit record year both on top line and adjusted EBITDA. Our Q1 results demonstrate that we are performing on track. We generated 12% organic growth in the quarter and 21% including acquisitions and converted that into 37% EBITDA growth. Two, our business model and strategy are working. We are on our way to the seventh consecutive year of record results and have achieved this through challenges such as global conflicts, the pandemic, labor shortages, inflationary pressures, and higher interest rates, to name just a few. Our business is solid and growing. Three, we are a consistent capital deployer. with an objective deploying over 100 million per year. So far in fiscal 24, we have deployed half of that with the decisive acquisition and have a robust M&A pipeline that we continue to pursue. We feel confident we have the opportunity to meet this objective by the end of the year. The combination of M&A and organic growth, coupled with our dedicated and talented team, continued investment and innovation across all that we do, and the globalization of the company will position us to continue to sustain our track record as a double-digit profitable growth company. On that note, I want to thank our staff for their commitment and dedication. They do make all the difference and are working extremely hard every day in support of our growth objectives. I also want to thank our customers for the loyalty, our suppliers for the collaboration, and our shareholders for the continued support. And with that, Shannon, I'd like to now open the call for questions.

Thank you. As a reminder, to ask a question, please press star 1-1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1-1 again. Please stand by while we compile the Q&A roster. Our first question comes from the line of Doug Taylor with Canaccord. Your line is now open.

Yeah, thank you. Good morning. I'd like to ask a question about the advanced technology section, segment. The acquisitive growth related to HPT last year implies, I think, a revenue contribution which would be well above what HPT was producing or the runway at the time of the acquisition. So I guess I wanted to speak to you about what's driving that. I understood that to be a largely recurring revenue business model. So to what degree is there a seasonal element to that? Or can you speak to success in cross-selling or expanding the existing customer base there?

Yeah, morning, Doug. Yeah, HVT has gotten off to a really strong start. We did win a project with a LEO operator and we're deploying all of that equipment for them. So there was a one-time increase in revenue because of that project. But that recurring component of the business you mentioned continues to be very strong and we're continuing to see that grow. I think so far it's been very positive and we want to commend the team there for great work. And I think the teams are really meshing together. So I think from a cross sell, I think there's still quite a lot of upside as the teams start to get together and try to make some of those opportunities come to fruition.

It's great to hear. Is that program, that project with the LEO operator now, I mean, the, I guess, one time or the hardware related, parts of that program complete now, or is that expected to extend here into the next couple quarters?

No, we expect it to go online here in RQ2 and start to deliver services on a recurring basis for that operator. So I think it's a big win for us.

Okay. Shifting gears here, the ITCS business. First, I just wanted to speak about the organic growth profile and the demand profile there. I mean, we've heard from a lot of other issuers that you know the enterprise spending environment you know has been slow for a couple quarters now as you sit here today can you speak to the near-term outlook for better organic growth and you know with that business as you roll out the new go-to-market strategy that you know under new leadership there yeah it's Kevin good morning um

I think neutral to positive for sure. I think from an IT market perspective and thinking how we go to market between our value-added resale, our consulting services, our cyber services, our managed services, we still see good demand. The commercial markets in the U.S., we were doing this yesterday, over 1,000 customers. We're supporting in some shape or form, some smaller, some larger. Mike is really taking a regional model approach to this, so really focusing in on our regions that we believe are growth opportunities and taking a customer first view into those regions. So a bit of a change in philosophy, I would say, and really trying to get close to those customers, including some of our largest customers. So while I support the other companies, I know there's some headwinds out there from an IT and expend, but we still see some very good opportunities. And I'm confident now with Mike and some of the changes he's made. And frankly, the team that's been there continues to work incredibly hard. And we'll soon see some organic growth over IT, probably single digits, and then continue to look for M&A opportunities to support more of a regional focus in certain areas that Mike wants to target. So, yep, I think it's positive. I think we'll continue to do well. And coming out of the blocks, I'm excited where Mike and the team are trying to take IT going forward.

Thanks. I'll save the rest for the investor event later today. I'll pass on. Thanks so much, Doug.

Thank you. Our next question comes from the line of Scott Fletcher with CIBC. Your line is now open.

Hi, good morning. I wanted to ask a question on the contribution from Decisive Group. I think the idea was that there was pretty significant seasonality and that Q2 would be the strongest quarter. Is that still the case? Are there any changes to how we should be thinking about how Decisive will contribute going forward?

Hey, Mark Scott. You know, strong start. As Kevin mentioned, they were part of the Calium for a month, so they had a good first month. Q2 is still the strongest quarter. I think as we work with the team and try to re-profile, I think we're seeing it a bit smoother throughout the year. So I think the second half will be stronger than maybe we indicated before with some of that coming off of Q2. But Q2 is still the strongest quarter, but maybe a bit less peaky than we said the previous time.

Okay, thanks. That's helpful. And then just on the guidance, on reiterating the guidance, I mean, a very strong Q1, do you have more confidence about getting to the upper end of that guidance range now that you sort of have a strong Q1 in the books?

Hi, good morning, Scott, Kevin. I think right now our guidance, you know, from our viewpoint, it represents, I think we're going to have another strong year. We're going to have another, you know, double-digit, you know, profitable growth year. I'd prefer not to comment on the specific ranges where we are at this point, just because I think coming out of Q1, reiterating our guidance, I think we're definitely still in that range. And I think coming out of Q2, we'll be in a better position to talk about, you know, where we're sitting in that range right now. We still have three quarters to go, so I don't want to get ahead of ourselves. That being said, the guidance we have issued, you know, will be another record year for Calium. So very confident that we can achieve that. Fair enough.

Thank you for that.

Thank you. Our next question comes from the line of Rob Goff with Echelon Capital Markets. Your line is now open.

Good morning, and thank you for taking my question. My question would turn over to the health side. Could you perhaps dive a little bit deeper into the increased demand? You referenced long-standing customers and short-term demands. Thank you.

Yeah, good morning. Yeah, really what we're seeing is it's kind of coming from a few different areas. From our legacy defense customer who we value really was the start of our healthcare business, we are seeing continued increased demand to support military requirements. And that's right across all the different categories of support from healthcare that we provide the military. So definitely continued strong demand to support the military in support of their missions. The second one is on our psychological services. Now, we've recently hired a new chief psychologist for the company, and psychological services nationally, as you know, is a major issue. We are becoming very specialized in psychological services support to first responders, first psychological support to the military, dealing with a whole bunch of different use cases, if I can say it that way. And so our national psychological services presence is strengthening, and we're seeing a lot of customers ping us on that now to support, and we all recognize some of the challenges we're having in the mental health area these days. The third is just on our general clinician services piece. Again, strong demand. We see post-COVID now that the workforce is back. We're having more opportunity. We've invested in our recruiting engine. We're looking at pilots on AI and how we actually get at our medical network more effectively. And I think that's paying dividends as well. And then our pharma business and our digital business are also doing well. So, you know, we continue to see new mandates for our patient support programs, contract research organization capability. And as I mentioned, we're actually starting to see some uptake now in our digital health portfolio. So the growth of the health business is not one thing. It is a few things that is happening in parallel. And Derek and the team are doing a great job. We've just invested in new sales Nancy, who I just joined the company, is a VP of sales. So we're pretty excited about where we're going. And as mentioned, that's all organic. So very excited we're in healthcare businesses today.

Great. Thank you. This is perhaps a bit too granular, but you made reference to the strength in cyber, both within the quarter and in the backlog. Is there anything further you could take it up?

Yeah, our cyber business continues to be probably the strongest one in our ITCS business. You know, we're seeing, you know, we worked with a few of our customers that had breaches. We were able to help them recover their networks. And we've continued to see, you know, strong, specifically in the healthcare market in Ontario, strong uptake for the services that we offer. So I think we're pretty optimistic that, you know, our product and our offering right now is really – hitting the right mark with our customers, and we're optimistic that we can continue to expand that here in the coming years.

That's great. Thank you very much.

Thank you.

Thank you. As a reminder, to ask a question at this time, please press star 1-1 on your touchstone telephone. Our next question comes from the line of Jonathan Lammers with Lowland Shin Bank Securities. Your line is now open.

Good morning. Starting on the gross margin percentage, nice to see the new record level there for the quarter. Just at a high level, could you review some of the shifts in business mix that you see driving that and how much of those are expected to continue over fiscal 24th? Good morning, Jonathan.

Yeah, I think this has been a concerted effort of ours for multiple years, and I think it's been a combination of our M&A agenda doing acquisitions that are bringing in businesses at higher margin profiles. I think you saw that with Decisive. You're seeing that with HPT. I think that's contributing. We've been continuing to, you know, a lot of our investment has been going into our own products where we can drive higher products, and that mix has continued to increase. I think it's probably multiple things, but I think all of them have been efforts we've been working on here for multiple years, and I think you're just starting to see that impact over time. So I think we're trying to, you know, keep it going and continue to accelerate that in the coming years. And we're going to talk about that at the investor day.

Yeah. And it's Kevin. I'd echo Patrick's comments. The other thing I'd say, and people that know me talk, you know, know how I passionate about the brand. I'm also seeing our brand get recognized now. Our brand's getting presence in our key markets. And while there's work to be done, we can establish the brand of successful delivery across mission-critical functions and do it consistently, whether it's emergency management, healthcare, IT, cyber, advanced technologies, learning, missions. Our brand is getting out there, and with that becomes the opportunity to increase margins just by the fact that people do want to work with Cali in the most critical processes.

So I think we're also starting to see the effect of that in our targeted market.

Great.

I'll leave more on that for the investor day. Just a question on the backlog. So if we look versus this time last year, there's a couple of shifts. The health portion of the backlog seems to be lower for this year. Sorry, a lot higher for this year, rather. Sorry, up to $137 million to be recorded in the balance of the year. The learning backlog is down a bit. you know, advanced tech we've seen down a bit. So I guess two questions. You know, one, is there anything in terms of seasonal timing going on there between health and learning? And, you know, could you just comment on how you expect that to impact the results over the balance of the year?

Yeah, I'm not seeing any impact this year. I think the reality both in health and learning, like we have several large contracts that, you know, we only recompete every five to ten years. So we are burning those off, which you can see in the backlog. But I think the positive this quarter was strong signings, $150 million in signings across the entire business. So that was a very positive note. And I don't think there's any dynamics there that are particularly concerning this year. I think it's going as we expected.

Yeah, thank you. And just in advanced tech, the backlog is down just a little bit. Does that reflect the shift in business toward –

know more short time short lead time type orders like gns antennas um away from longer term contracts or am i reading too much into that no i think you're right the mix well i think that's where you're seeing the margins the mix is going more towards our products which generally we're getting orders and delivering them you know within six to eight weeks depending on any supply chain issues and this is different than if you think three four years ago when much of the backlog was large ground system projects which are multi-year projects, which bring longer backlogs. I think it's just been a shift in the mix, but I think the positive has been the margin impact. I think you've seen that in the results.

Okay, thank you. And I noticed on the slides, it now says that you're targeting capital deployment of over $100 million per year. Has that target moved up as you've introduced your new strategic plans?

Yeah, and that's going to be a highlight today at the investor day. So we're going to talk about how we, you know, increase the pace of our capitalist loan. I think it's been a huge success for the company over the last five years. And part of getting to a billion is going to be, you know, continue to do the same thing we're doing, but at an increased pace. And I think that's going to be something we're going to dig into today at the investor day. Okay, thanks for your comments. Thanks, Jonathan.

Thank you. Our next question comes from the line of Michael Kiprios with Desjardins. Your line is now open.

Good morning and congrats on the strong quarter. Maybe just on SG&A, it looks like sequentially it took a bit of a step up in the quarter. Was that main, what was the main driver of this and is there any way related to the acquisition and should we expect to step back down as we approach the second quarter?

Yeah, good morning, Michael. More than half of that was really the acquisitions of HPT and Decisive. So, you know, HPT and for a full quarter versus the Q4 partially and then Decisive coming in. So I think a lot of it's been just the acquisition impact. Also spending money kind of on our M&A pipeline right now that we're working. And the rest was just kind of just more natural growth in line with revenue.

Perfect. I appreciate it. And now that you have your full hands on Decisive with the acquisition closing, do you have any maybe incremental tidbits that you've discovered since getting your hands on the business?

I think so far so good. I mean, we really like this business. The team's been excellent. They're in Ottawa with us. And I think after meeting with the team, I think there's, you know, I think the similarities and being able to work together is evident. And I think that we've only, you know, the interaction so far have only reinforced that. So we're really looking forward to a positive year with the team. I appreciate it. Good luck with the investor. Thank you. Thanks, Michael.

Thank you, and I'm currently showing no further questions at this time. I'd like to hand the call back over to Kevin Ford for closing remarks.

Thank you, Shannon, for facilitating today's call. It's very much appreciated. I'd like to mention, as you heard on the call today, that we'll be hosting our AGM and Investor Day today in Toronto. We're here at the Global Mail Center. We're actually doing this from the Global Mail Center this morning, so it's a beautiful view, 17 floors above. So I'm hoping to see you folks and other folks on the call today. I hope to see you here. So on that note, I'd like to thank each of you for attending, and we look forward to providing you with an update at our next quarterly call. And with that, Shannon, we can close the call.

This concludes today's conference call. Thank you for your participation. You may now disconnect. Thank you. Thank you. you Thank you. Good day, and thank you for standing by. Welcome to the CALIAN Group first quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference has been recorded. I would now like to hand the conference over to your speaker today, Jennifer McCaughey, Director of Investor Relations. Please go ahead.

Thank you, Shannon, and good morning, everyone. Thank you for joining us for Callion's Q1 and fiscal year 2024 conference call. Presenting this morning are Kevin Ford, Chief Executive Officer, and Patrick Houston, Chief Financial Officer. As noted on slide two, please be advised that certain information discussed today is forward-looking, and subject to important risks and uncertainties. The results predicted in these statements may be materially different from actual results. As a reminder, all amounts are expressed in Canadian dollars, except as otherwise specified. With that, let me turn the call over to Kevin.

Good morning, and thank you, Jennifer. I'd like to start by saying that you will increasingly hear me talk about Callion on a consolidated basis. While we manage the different segments as distinct P&Ls, We're judging the performance of the company on a consolidated basis. Now for some Q1 highlights. We had a strong start to the year with revenues up 21% driven by double-digit organic growth and the contribution from two recent acquisitions. Organic growth outpaced M&A growth this quarter. Steps to improve our efficiency are bearing fruit with gross margin at an all-time high of 32.5% and adjusted EBITDA margin bordering 11%. These results demonstrate the strength of our business model, our diversification in new markets and offerings, as well as the value creation generated from our M&A agenda. In fact, our M&A engine is working with the completion of two acquisitions in the past six months for a total consideration of approximately $100 million. Notable highlights in Q1 include the completion of the decisive acquisition, which will form a key part of our ITS strength in North America, and we welcome Michael Trombley as president of our IT and Cyber Services group. The contribution from our recent acquisition of Hawaii Pacific Teleport continues to be a highlight, and our sales engine was able to secure $150 million in new signings this quarter. Given these strong results, we are reiterating our fiscal 24 guidance, which puts us on track to deliver our seventh consecutive year of double-digit profitable revenue growth. This strong performance is an early indicator of our path to reach $1 million in revenues by the end of fiscal 26. Now, I will turn over to Patrick to discuss consolidated results and guidance for fiscal 24. Over to you, Patrick.

Thank you, Kevin. Q1 revenues reached $179 million, up 21% compared to the same period last year, and represents the highest revenue quarter in our history. This increase was driven by growth across all four segments, including double-digit growth in health, ITCS, and advanced technologies. Acquisitive growth was 9% and was generated by the acquisitions of HPT and Decisive. Organic growth was 12% and was mainly determined by double-digit growth in health and advanced technologies. Our steps to restore efficiency are clearly working. Gross margin reached a record 32.5%, representing a seventh consecutive quarter above 30%, and the first time above 32%. Adjusted EBITDA increased 37% to $20 million, driven by strength, overall revenue growth, and margin expansion in advanced technologies and health, as well as from benefits generated from the restructuring plan implemented midway through our fourth quarter. Adjusted EBITDA margin reached 10.9%, up from 9.7% in the previous year. In Q1, we signed $150 million in gross new contracts. ended the quarter with a backlog of 1.1 billion positioning as well for the balance of this year and into fy25 net profit in q1 increased to 5.5 million or 46 cents per diluted share compared to 4.6 million or 39 cents per share for the same period last year the increase was mainly driven by higher adjusted evida partially offset by higher expenses related to acquisitions and higher interest expenses as we drew on our credit facility to fund the acquisitions of HPT and Decisive. Noted in FY24, we are expecting to pay the year to earn out for Simfront. This amount is recorded on our balance sheet. We generated cash flow from operations of $18 million in Q1, down from $25 million last year. Working capital was neutral in the quarter, while we had significant recapture in Q1 of last year. When we take working capital on our balance sheet and put it in relation to our revenue generation, we've made great strides in recent years. In FY20, we required $92 million in working capital to generate $432 million of revenue, or 21% efficiency. In FY23, we now required $90 million to generate $659 million of revenues, or 14% efficiency. In Q1, we required $71 million of working capital to generate the last 12 months of revenue of almost $700 million, or 10%. Going forward, we'll be looking to drive more efficiency in working capital as we continue to deliver double-digit revenue growth. Operating free cash flow was up 17% to $14 million and represented a 73% conversion from adjusted EBITDA. Looking at it through a shareholder lens, our operating free cash flow per share increased 15% to $1.20 per share. We continue to have a disciplined and balanced approach to capital deployment in the first quarter. We invested in our business with the acquisition of Decisive for $47 million. We also made CapEx investments of $2 million. Our CapEx levels have remained stable despite significant increase in the size of our business over the last few years. We continue to invest in capital to help us scale and not inhibit our growth aspirations. We also provide a return to shareholders in the form of a dividend and share repurchases. We pay dividends of $3 million or $0.28 per share. representing 23% of operating free cash flows. In Q1, we continued to repurchase shares through our NCIB program we put in place on September 1st. We purchased 27,226 shares for cancellation for approximately $1 million. Since the launch of the NCIB plan, we've repurchased just under 60,000 shares for cancellation of approximately $3 million. Although we believe our share price remains undervalued, our capital allocation priority is still our M&A agenda. As a result, any future dividend increases or share repurchase decisions will be evaluated in the context of this while being mindful of our leverage. After making all these investments, we ended the quarter with a solid balance sheet. As of December 31st, we had drawn $94 million on our debt facility, and we had net debt of $41 million. and a net debt to EBITDA ratio of 0.6 times, well below our target of 2.5 times. We maintain considerable debt capacity with our existing lenders and staying within our 2.5 times EBITDA leverage target to further fund our M&A agenda. Let's take a look at our guidance for FY24. Given our strong start to the year and our confidence for the balance of the year, we are reiterating our guidance. As a reminder, we expect revenues in the range of $730 to $790 million for the year ended September 30, 2024. At the midpoint, this reflects revenue growth of 15%. This would represent our seventh consecutive year of double-digit growth and record levels. In this guidance, the acquisition of the HPT and Decisive represent approximately 7% acquisitive growth over last year. At the midpoint of the range, organic growth would represent 8%. When taking into account Q1 revenues of $179 million, our $342 million of backlogged earmarked for the remainder of FY24, our deferred revenues of $30 million, and our recurring revenue streams of approximately $30 million, we have 76% of FY24 already booked and ready to deliver. In terms of profitability, we expect adjusted EBITDA in the range of $83 to $89 million. At the midpoint, it reflects adjusted EBITDA growth of 30%. significantly outpacing our revenue growth. This is a result of expanding our business into higher margin areas as well as the full year benefit of our restructuring plan. It also implies a margin of 11.3%. With this guidance, we're on track to achieve another record year at FY24 and are off to a great start to achieve our 1 billion revenue target by the end of FY26. As a reminder, we're expecting to see increased fluctuation in our quarterly results due to our revenue mix, which is more highly skewed towards products, where the timing of deliveries come into play, as well as commercial customers characterized by greater demand variability. As always, we must caution that this guidance is ultimately dependent on the extent and timing of future contract awards and customer realization of existing contract vehicles. The guidance also implies no major changes to current economic environments, defense spending, and supply chains as well as no major increases in interest rates or labor costs. Note that our guidance does not incorporate any additional M&A activity than those already mentioned, and should we close any new opportunities, their contributions would be incremental. Finally, in terms of capital deployment for the year, earn out payments should be approximately $3 million. We continue to have a robust pipeline of acquisitions, and we're working hard to close a few of those in the balance of FY24. We expect to maintain our capex investments in the range of $8 to $10 million and our current dividend at $1.12 per share. We believe this guidance reflects the strength of our business and momentum coming off a very strong quarter. I'll now turn the call back over to Kevin to provide color on our business segment. Kevin?

Thank you, Patrick. Let me start with our ITCS segment. As mentioned, major highlights in this quarter include the start of Mike Tremblay as president and the acquisition of Decisive, and continued margin recovery. Mike has been on board for about two months now and has met with the teams in Ottawa, Toronto, and Houston, and has quickly assessed the people and assets we have. He is already implementing changes to our strategy and go-to-market business model, which are suspected to just support higher sales generation. Recall that Decisive closed December 1st, so it has only contributed one month and a quarter. Early interactions with the excellent team, as well as key customers, have been positive, and we believe this acquisition will be a great asset moving forward. When looking at our EBITDA margins, we are back in the 14% range, similar to where we were at the beginning of last year. These are solid signs that the assets in our ITCS business are strong, and I look forward to working with Mike to drive future growth across North America. We also entered Q1 with new contract signings of $62 million, an indication that bookings continue to be healthy. With the full-year benefit and the cost reductions implemented in Q4 and the addition of Decisive, which complements and rounds out our current IT and cyber solutions portfolio in North America, we are well-positioned to extract a lot of synergies over the next 24 months. Turning to our health segment. The major highlights this quarter are the continued growth momentum, both from a top-line and profitability perspective, digital opportunities on the horizon, and investments in growth. We had a strong performance coming off of record Q4 with revenues up over 24% and adjusted EBITDA up 46%. This growth is all organic. We continue to experience strong demand from our long-standing customers, as well as short-term health response demand, which is characterized by higher margins. Furthermore, we're seeing exciting opportunities in our digital platform. We onboarded two customers so far and have a promising pipeline. These early wins reinforce our willingness to invest more, and in fact, we'll be investing in our sales capacity to get more feet on the street to sell both our service and digital product portfolio. With new contract signings of $40 million and a solid backlog of $626 million, we believe that revenues of $200 million per year are in sight for the first time in the company's history. The M&A environment and health has improved, and we are looking to deploy capital to further accelerate our growth in this segment. Turning to our learning segments. As we mentioned last quarter, the pace of growth for learning has started to slow down due to longer procurement decisions. However, we continue to see strong activity from existing customers, driven by global conflicts, and a renewed focus on readiness. What is exciting is that we are seeing some good defense opportunities, both domestically and globally, as well as in the commercial market. We recently hired a VP sales to help bring them to fruition. At the same time, we're also continuing to invest in growth to make sure we are well positioned to capitalize on the macro environment where military training is mission critical. We believe the global defense market will yield future opportunities. It is just a matter of time. In the balance of the year, we will focus on upping our sales engine, unlocking opportunities and targeting acquisitions to strengthen our presence in Europe, and complement our diversification and innovation strategy. Turning to our advanced tech segment. The major highlights for Advanced Tech this quarter are its continued growth momentum, especially with its product portfolio and the solid contribution from Hawaii Pacific Teleport. We are pleased to see AT have a strong start to the year, continuing the momentum generated in the latter part of last year. Revenues increased 49% to $51 million from $34 million last year when the segment was dealing with supply chain issues. This represents the second consecutive quarter above the $50 million mark for our Advanced Technologies Group. This performance was driven in part by the space segment, mainly from performance from our software business and the first full quarter contribution from HPT. This top-line growth was also driven by a terrestrial segment where our products portfolio, including GNSS, AgTech, and nuclear, continued to demonstrate significant growth. We have not spoken about defense and AT recently. However, we do see signs of increased demand as procurement starts to finalize plans on large capital programs. It's just a matter of time before these opportunities turn to revenue. Given this higher volume and sales mix, gross margins hit an all-time record above 36%, and adjusted EBITDA more than doubled to $9 million. With continued strong demand for our products, the contribution from HPT, new contract signings of $44 million, and a solid backlog of $142 million, we expect to surpass the $200 million revenue in FY24 again for the first time in company history. EBITDA margins should also increase given the higher margin of HPT contribution and favorable revenue mix. Lastly, I wanted to announce that Patrick Thera, President of Advanced Technologies, recently informed us that he will be retiring after a lustrous 38-year career with Calium. Patrick played a pivotal role in shaping the success of the Advanced Technologies segment. I am immensely grateful for his dedication, stage counsel, and commitment to the business. We will remain at the helm of the segment while we conduct a search for a successor and we look forward to working on a successful transition. In conclusion, I'd like to leave you with three key takeaways. One, our guidance reflects another double digit record year both on top line and adjusted EBITDA. Our Q1 results demonstrate that we are performing on track. We generated 12% organic growth in the quarter and 21% including acquisitions and converted that into 37% EBITDA growth. Two, our business model and strategy are working. We are on our way to the seventh consecutive year of record results and have achieved this through challenges such as global conflicts, the pandemic, labor shortages, inflationary pressures, and higher interest rates, to name just a few. Our business is solid and growing. Three, we are a consistent capital deployer. with an objective deploying over 100 million per year. So far in fiscal 24, we have deployed half of that with the decisive acquisition and have a robust M&A pipeline that we continue to pursue. We feel confident we have the opportunity to meet this objective by the end of the year. The combination of M&A and organic growth, coupled with our dedicated and talented team, continued investment and innovation across all that we do, and the globalization of the company will position us to continue to sustain our track record as a double-digit profitable growth company. On that note, I want to thank our staff for their commitment and dedication. They do make all the difference and are working extremely hard every day in support of our growth objectives. I also want to thank our customers for the loyalty, our suppliers for the collaboration, and our shareholders for the continued support. And with that, Shannon, I'd like to now open the call for questions.

Thank you. As a reminder, to ask a question, please press star 1-1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1-1 again. Please stand by while we compile the Q&A roster. Our first question comes from the line of Doug Taylor with Canaccord. Your line is now open.

Yeah, thank you. Good morning. I'd like to ask a question about the advanced technology section, segment. the acquisitive growth related to HPT last year implies, I think a revenue contribution, which would be well above what HPT was, you know, producing or the runway at the time of the acquisition. So I guess I wanted to speak to you about what's driving that. I understood that to be a largely recurring revenue business model. So to what degree is there a seasonal element to that? Or, you know, can you speak to success in cross-selling or expanding the existing customer base there?

Yeah. Morning, Doug. Yeah, HPT has gotten off to a really strong start. We did win a project with a LEO operator and we're deploying all of that equipment for them. So there was a one-time increase in revenue because of that project. But that recurring component of the business you mentioned continues to be very strong and we're continuing to see that grow. So I think so far it's been very positive. And I want to commend the team there for great work. And I think the teams are really meshing together. So I think from a cross-sell, I think there's still quite a lot of upside as the teams start to get together and try to make some of those opportunities come to fruition.

It's great to hear. Is that program, that project with the LEO operator now, I mean, the, I guess, one-time or the hardware-related project, parts of that program complete now, or is that expected to extend here into the next couple quarters?

No, we expect it to go online here in RQ2 and start to deliver services on a recurring basis for that operator. So I think it's a big win for us.

Okay. Shifting gears here, the ITCS business. First, I just wanted to speak about the organic growth profile and the demand profile there. I mean, we've heard from a lot of other issuers that the enterprise spending environment has been slow for a couple quarters now. As you sit here today, can you speak to the near-term outlook for better organic growth with that business as you roll out the new go-to-market strategy under new leadership there?

Yeah, Doug. It's Kevin. Good morning. I think neutral to positive for sure. I think from an IT market perspective and thinking how we go to market between our value-added resale, our consulting services, our cyber services, our managed services, we still see good demand. The commercial markets in the US, we were doing this yesterday, over 1,000 customers were supporting in some shape or form, some smaller, some larger. Mike is really taking a regional model approach to this, so really focusing in on our regions that we believe are growth opportunities and taking a customer-first view into those regions. So a bit of a change in philosophy, I would say, and really trying to get close to those customers, including some of our largest customers. So while I support the other companies, I know there's some headwinds out there from an IT and expend, but we still see some very good opportunities, and I'm confident now with Mike and some of the changes he's made. And frankly, the team that's been there continues to work incredibly hard And we'll soon see some organic growth over IT, probably single digits, and then continue to look for M&A opportunities to support more of a regional focus in certain areas that Mike wants to target. So, yeah, I think it's positive. I think we'll continue to do well. And coming out of the blocks, I'm excited where Mike and the team are trying to take IT going forward.

Thanks. I'll save the rest for the investor event later today. I'll pass on. Thanks so much, Doug.

Thank you. Our next question comes from the line of Scott Fletcher with CIBC. Your line is now open.

Hi, good morning. I wanted to ask a question on the contribution from Decisive Group. I think the idea was that there was pretty significant seasonality and that Q2 would be the strongest quarter. Is that still the case? Are there any changes to how we should be thinking about how Decisive will contribute going forward?

Hey, Mark Scott. You know, strong start. As Kevin mentioned, they were part of the Calium for a month, so they had a good first month. Q2 is still the strongest quarter. I think as we work with the team and try to re-profile, I think we're seeing it a bit smoother throughout the year. So I think the second half will be stronger than maybe we indicated before with some of that coming off of Q2. But Q2 is still the strongest quarter, but maybe a bit less peaky than we said the previous time.

Okay, thanks. That's helpful. And then just on the guidance, on reiterating the guidance, I mean, a very strong Q1, do you have more confidence about getting to the upper end of that guidance range now that you sort of have a strong Q1 in the books? Hi.

Good morning, Scott. Kevin. I think right now our guidance, you know, from our viewpoint, it represents I think we're going to have another strong year. We're going to have another, you know, double-digit, you know, profitable growth year. I'd prefer not to comment on the specific ranges where we are at this point, just because I think coming out of Q1, reiterating our guidance, I think we're definitely still in that range. And I think coming out of Q2, we'll be in a better position to talk about, you know, where we're sitting in that range right now. We still have three quarters to go, so I don't want to get ahead of ourselves. That being said, the guidance we have issued, you know, will be another record year for Calium. So very confident that we can achieve that.

Fair enough. Thank you for that.

Thank you. Our next question comes from the line of Rob Goff with Echelon Capital Markets. Your line is now open.

Good morning, and thank you for taking my question. My question would turn over to the health side. Could you perhaps dive a little bit deeper into the increased demand? You referenced long-standing customers and short-term demands. Thank you.

Yeah, good morning. Yeah, really what we're seeing is it's kind of coming from a few different areas. From our legacy defense customer who we value really was the start of our healthcare business, we are seeing continued increased demand to support military requirements. And that's right across all the different categories of support from healthcare that we provide the military. So definitely continued strong demand to support the military in support of their missions. The second one is on our psychological services. Now, we've recently hired a new chief psychologist for the company, and psychological services nationally, as you know, is a major issue. We are becoming very specialized in psychological services support to first responders, first psychological support to the military, dealing with a whole bunch of different use cases, if I can say it that way. And so our national psychological services presence is strengthening, and we're seeing a lot of customers ping us on that now to support, and we all recognize some of the challenges we're having in the mental health area these days. The third is just on our general clinician services piece. Again, strong demand. We see post-COVID now that the workforce is back. We're having more opportunity. We've invested in our recruiting engine. We're looking at pilots on AI and how we actually get at our medical network more effectively. And I think that's paying dividends as well. And then our pharma business and our digital business are also doing well. So, you know, we continue to see new mandates for our patient support programs, contract research organization capability. And as I mentioned, we're actually starting to see some uptake now in our digital health portfolio. So the growth of the health business is not one thing. It is a few things that is happening in parallel. And Derek and the team are doing a great job. We've just invested in new sales. Nancy, who I just joined the company, is a VP of sales. So we're pretty excited about where we're going there. And as mentioned, that's all organic. So very excited where the healthcare business is today.

Great. Thank you. This is perhaps a bit too granular, but you made reference to the strength in cyber, both within the quarter and in the backlog. Is there anything further you could pick it up?

Yeah, cyber business continues to be probably the strongest one in our ITCS business. You know, we're seeing, you know, we worked with a few of our customers that had breaches. We were able to help them recover their networks. And we've continued to see, you know, strong, specifically in the healthcare market in Ontario, strong uptake for the services that we offer. So I think we're pretty optimistic that, you know, our product and our offering right now is really... hitting the right mark with our customers, and we're optimistic that we can continue to expand that here in the coming years.

That's great. Thank you very much.

Thank you.

Thank you. As a reminder, to ask a question at this time, please press star 1-1 on your touchstone telephone. Our next question comes from the line of Jonathan Lammers with Lowland Shin Bank Securities. Your line is now open.

Good morning. Starting on the gross margin percentage, nice to see the new record level there for the quarter. Just at a high level, could you review some of the shifts in business mix that you see driving that and how much of those are expected to continue over fiscal 24th?

Good morning, Jonathan. Yeah, I think this has been a concerted effort of ours for multiple years, and I think it's been a combination of our M&A agenda doing acquisitions that are bringing in businesses at higher margin profiles. I think you saw that with Decisive. You're seeing that with HPT. I think that's contributing. A lot of our investment has been going into our own products where we can drive higher products, and that makes us continue to increase. I think it's probably multiple things, but I think all of them have been efforts we've been working on here for multiple years, and I think you're just starting to see that impact over time. So I think we're trying to keep it going and continue to accelerate that in the coming years. And we're going to talk about that at the investor day.

Yeah. And it's Kevin. I'd echo Patrick's comments. The other thing I'd say, and people that know me talk, you know, know how I passionate about the brand. I'm also seeing our brand get recognized now. Our brand's getting presence in our key markets. And while there's work to be done, we can establish the brand of successful delivery across mission-critical functions and do it consistently, whether it's emergency management, healthcare, IT, cyber, advanced technologies, learning, missions. Our brand is getting out there, and with that becomes the opportunity to increase margins just by the fact that people do want to work with county in the most critical processes.

So I think we're also starting to see the effect of that in our targeted market.

Great.

I'll leave more on that for the investor day. Just a question on the backlog. So if we look versus this time last year, there's a couple of shifts. The health portion of the backlog seems to be lower for this year. Sorry, a lot higher for this year, rather. Sorry, up to $137 million to be recorded in the balance of the year. The learning backlog is down a bit. you know, advanced tech we've seen down a bit. So I guess two questions. You know, one, is there anything in terms of seasonal timing going on there between health and learning? And, you know, could you just comment on how you expect that to impact the results over the balance of the year?

Yeah, I'm not seeing any impact this year. I think the reality both in health and learning, like we have several large contracts that, you know, we only recompete every five to ten years. So we are burning those off, which you can see in the backlog. But I think the positive this quarter was strong signings, $150 million in signings across the entire business. So that was a very positive note. And I don't think there's any dynamics there that are particularly concerning this year. I think it's going as we expected.

Yeah, thank you. And just in advanced tech, the backlog is down just a little bit. Does that reflect the shift in business toward – you know, more short lead time type orders like GNS antennas away from longer term contracts, or am I reading too much into that?

No, I think you're right. The mix, well, I think that's where you're seeing the margins. The mix is going more towards our products, which generally we're getting orders and delivering them, you know, within six to eight weeks, depending on any supply chain issues. And this is different than if you think three, four years ago when much of the backlog was large ground system projects, which are multi-year projects, which bring longer backlogs. I think it's just been a shift in the mix, but I think the positive has been the margin impact. I think you've seen that in the results.

Okay, thank you. And I noticed on the slides, it now says that you're targeting capital deployment of over $100 million per year. Has that target moved up as you've introduced your new strategic plans?

Yeah, and that's going to be a highlight today at the investor day. So we're going to talk about how we, you know, increase the pace of our capital employment. I think it's been a huge success for the company over the last five years. And part of getting to a billion is going to be, you know, continue to do the same thing we're doing, but at an increased pace. And I think that's going to be something we're going to dig into today at the investor day. Okay. Thanks for your comments. Thanks, Jonathan.

Thank you. Our next question comes from the line of Michael Kiprios with Desjardins. Your line is now open.

Good morning and congrats on the strong quarter. Maybe just on SG&A, it looks like sequentially it took a bit of a step up in the quarter. Was that main, what was the main driver of this and is there any way related to the acquisition and should we expect to step back down as we approach the second quarter?

Yeah, good morning, Michael. More than half of that was really the acquisitions of HPT and Decisive. So, you know, HPT and for a full quarter versus the Q4 partially and then Decisive coming in. So I think a lot of it's been just the acquisition impact. Also spending money kind of on our M&A pipeline right now that we're working and the rest was just kind of just more natural growth in line with revenue.

Perfect. I appreciate it. And now that you have your full hands on Decisive with the acquisition closing, do you have any maybe incremental tidbits that you've discovered since getting your hands on the business?

I think so far so good. I mean, we really like this business. The team's been excellent. They're in Ottawa with us. And I think after meeting with the team, I think there's, you know, I think the similarities and being able to work together is evident. And I think that we've only, you know, the interaction so far have only reinforced that. So we're really looking forward to a positive year with the team. I appreciate it. Good luck with the investor. Thank you. Thanks, Michael.

Thank you. And I'm currently showing no further questions at this time. I'd like to hand the call back over to Kevin Ford for closing remarks.

Thank you, Shannon, for facilitating today's call. It's very much appreciated. I'd like to mention, as you heard on the call today, that we'll be hosting our AGM and Investor Day today in Toronto. We're here at the Global Mail Center. We're actually doing this from the Global Mail Center this morning, so it's a beautiful view, 17 floors above. So I'm hoping to see you folks and other folks on the call today. I hope to see you here. So on that note, I'd like to thank each of you for attending, and we look forward to providing you with an update on our next quarterly call. And with that, Shannon, we can close the call.

This concludes today's conference call. Thank you for your participation. You may now disconnect.